Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a study of MEDI0382 versus placebo on body weight and energy intake in overweight or obese adults with type 2 diabetes mellitus
2018-001220-19Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and obesity comparing MEDI0382 with Placebo (2 arms). Primary endpoint: Percentage change in body weight. Started Jun 2018; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on 2018-001220-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001220-19.